At Eurofins Viracor, we uphold the highest standards with our CAP accreditation, CLIA licensing, and NYSDOH certification. Our rigorous surveillance and re-validation processes ensure assay integrity, and our innovative dual-gene target assay design enhances accuracy and reliability. With over 40 years of specialized expertise in infectious disease, immunology, and allergy testing for immunocompromised and critical patients, Eurofins Viracor is experienced in and committed to helping medical professionals, transplant teams, and reference labs get results faster, when it matters most. We are also proud to be at the forefront of innovation with cutting-edge tests like ExPeCT™ anti-CD19 CAR T and NeXGen™ Fungal / AFB NGS, designed to meet the evolving needs of healthcare providers and improve patient outcomes through precision diagnostics.
Fast Results.
Turnaround time for most of our Infectious Disease testing is the same day (8-12 hours) as specimen receipt, getting you lab results faster for the patients who need it most.
Accurate Detection.
Our assays are designed with dual targets and multiple probes — accounting for all viral serotypes, genotypes or isolates that could affect patients — which reduce the incidence of under-quantification and false negative results, and detect strains that otherwise could have been missed.
More Specimen Options.
From plasma to BAL to tissue, we accept over 20+ validated specimen types to meet your patients' testing needs.